LexDanaLexDanabeta
Inventor

LIHUA YANG

Inventor
CN

Overview

2→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07DHeterocyclic compounds17%
C07KPeptides17%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
Y02ATechnologies for adaptation to climate change17%
PatentTitleYear
11,874,275Method for fluorescent immunoassay (FIA) and chemiluminescent immunoassay (CLIA) based on electrokinetic acceleration202411,813,306Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to NOVARTIS AG (1)· patent assignee history
2023Based in US· patent location history
2024Patents assigned to FOSHAN MICROWONDERS BIOTECHNOLOGY CO LTD (1)· patent assignee history
2024Based in CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
FOSHAN MICROWONDERS BIOTECHNOLOGY CO LTD12024
NOVARTIS AG12023
Locations
LocationPatentsSpan
CN12024
US12023